Literature DB >> 6971939

Modulation of human antibody production in vitro by D-penicillamine and CuSO4: inhibition of helper T cell function.

P E Lipsky.   

Abstract

Pokeweed mitogen (PWM), a T cell dependent, polyclonal B cell activator, stimulates the differentiation of immunoglobulin secreting cells (ISC) from normal human peripheral blood mononuclear cells (PBM). In this in vitro study, PBM failed to generate ISC in response to PWN after brief exposure to penicillamine and CuSO4; preincubation with either penicillamine or CuSO4 alone had no effect. Experiments utilizing purified populations of B and T cells indicated that penicillamine and CuSO4 markedly inhibited helper T cell activity but not B cell function. These observations may explain the effectiveness of penicillamine in rheumatoid arthritis, especially in decreasing rheumatoid factor titers.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6971939

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  4 in total

1.  Effect of drug therapy on circulating and synovial fluid Ig-secreting cells in rheumatoid arthritis.

Authors:  S Al-Balaghi; H Ström; E Möller
Journal:  Ann Rheum Dis       Date:  1985-04       Impact factor: 19.103

2.  Effects of D-penicillamine on a model of oxygen-derived free radical mediated tissue damage.

Authors:  W H Betts; L G Cleland; D J Gee; M W Whitehouse
Journal:  Agents Actions       Date:  1984-02

3.  Two mechanisms of inhibition of human lymphocyte proliferation by soluble yeast mannan polysaccharide.

Authors:  R D Nelson; M J Herron; R T McCormack; R C Gehrz
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

4.  Protective Effects of D-Penicillamine on Catecholamine-Induced Myocardial Injury.

Authors:  Michal Říha; Pavlína Hašková; Jan Martin; Tomáš Filipský; Kateřina Váňová; Jaroslava Vávrová; Magdalena Holečková; Pavel Homola; Libor Vítek; Vladimír Palicka; Tomáš Šimůnek; Přemysl Mladěnka
Journal:  Oxid Med Cell Longev       Date:  2015-12-14       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.